Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the efficacy of CJ-12420, once daily (QD),
compared to esomeprazole in patients with erosive esophagitis classified as Los Angeles (LA)
classification grades A to D at Week 8